Incucyte data from macrophage chemotaxis/migration assays with the mean represented as ±SD. (D) BMDM chemotaxis assay from conditioned medium from another set of PDAC-derived cell lines -the KC2 (blue) and KFC2 (grey) tumor-derived cell lines -measured over 80 hours. (E) BMDM migrationscratch wound assays looking at wound closure in the presence of conditioned medium from the KC2 (blue) and KFC2 (grey) cell lines over 50 hours measuring relative wound density. F. Luminex cytokine array performed on conditioned media from 3 independently derived KC (black) and KFC (red) cell lines. IL2, IFNa, IL31, and IL10 were detected. Graph shows fold change from one KC cell line and the mean is represented as ±SEM of biological replicates. G-H. Subcutaneous growth of 2 independent p53 WT cell lines, KC2 (blue) and KC3 (teal), and p53-null cell lines, KFC2 (grey) and KFC3 (orange) in CD1 nu/nu recipients with the mean represented as ±SEM of cohort sizes of n=5. All tumor derived cell lines were transduced with iRFP and growth was measured as relative growth to fluorescence at day 1 post injection by the Pearl Imager. I. Flow cytometry representative plot of intratumoral surface expression of Nkp46 + and CD11b + immune cells (left) from individual tumors arising either from the KC1 or KFC1 cell line. Right representative plots are gated on CD11b + Nkp46populations and analyzed for F4/80 and Ly6G expression of tumors derived from the KC1 and KFC1 cell lines. Statistical p-values are denoted as *p<0.05 and ** p< p<0.01. 
Figure S2. p53 deletion retards tumor regression and increases myeloid infiltration, Related to

